This conclusion is particularly compelling when the experimental data (cell line and clinical studies) is compared to the meta-analysis of ID4 promoter (UCSC genome browser) and remarkable mutually exclusive expression profile of EZH2 and ID4 in prostate cancer (TCGA datasets and experimental evidence). This evidence concerns the gene ID4 and Familial prostate cancer.